Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201109177 Principal Investigator: Pusic, Iskra
Title: A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Cell Transplantation
Phase: II Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions		 West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to see if cutaneous sclerosis improves with the use of Rituximab or Imatinib.
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)